Direct vasoconstrictor action of homologous angiotensin II on isolated arterial ring preparations in an elasmobranch fish

J Endocrinol. 1998 Sep;158(3):419-23. doi: 10.1677/joe.0.1580419.

Abstract

Arterial rings were prepared from the branchial artery, coeliac artery and ventral aorta of the Japanese dogfish Triakis scyllia and used to determine arterial contraction in a myograph. Noradrenaline caused a dose-dependent contraction (10(-9)-3 x 10(-6) M) that was completely inhibited by pre-treatment with 10(-7) M phentolamine. Homologous dogfish angiotensin II (ANG II) ([Asn1, Pro3, Ile5]-ANG II) also caused dose-dependent contraction (10(-9)-3 x 10(-6) M), but phentolamine had no effect on this response. Administration of dogfish angiotensin I (ANG-I) ([Asn1, Pro3, Ile5, Gln9]-ANG I) resulted in a contraction similar to that produced by ANG II and the effect could be blocked with 10(-7) M captopril. The mammalian ANG II receptor antagonists [Sar1, Ile8]-ANG II and [Sar1, Ala8]-ANG II caused dose-dependent contractions of coeliac artery rings, but were less potent than homologous ANG I and ANG II. These results show that the contractile effect of [Asn1, Pro3, Ile5]-ANG II is not mediated by the alpha-adrenergic system and contractions of arterial rings by noradrenaline and elasmobranch ANG II are mediated by separate vascular receptors. The elasmobranch ANG II vascular receptor may have co-evolved with the unusual structure of this peptide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-Antagonists / pharmacology
  • Angiotensin I / pharmacology
  • Angiotensin II / analogs & derivatives
  • Angiotensin II / pharmacology*
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Animals
  • Aorta
  • Blood Vessels / drug effects*
  • Brachial Artery
  • Captopril / pharmacology
  • Celiac Artery
  • Dogfish / metabolism*
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Mammals
  • Norepinephrine / pharmacology
  • Phentolamine / pharmacology
  • Receptors, Angiotensin / metabolism*
  • Saralasin
  • Vasoconstriction*

Substances

  • Adrenergic alpha-Antagonists
  • Angiotensin Receptor Antagonists
  • Angiotensin-Converting Enzyme Inhibitors
  • Enzyme Inhibitors
  • Receptors, Angiotensin
  • Angiotensin II
  • angiotensin II, Sar(1)-Ile(5)-
  • Angiotensin I
  • Captopril
  • Saralasin
  • Norepinephrine
  • Phentolamine